Clinical Trial Update: Carboplatin/Pralatrexate in Recurrent Platinum-Sensitive Ovarian, Fallopian or Primary Peritoneal Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating carboplatin/pralatrexate in recurrent platinum-sensitive ovarian, fallopian tube, or primary peritoneal cancer completed with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• carboplatin/pralatrexate

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Ovarian Cancer, Fallopian Tube Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-01-19